Engineering the End of Radical Prostatectomy

Gurus, what if treating prostate cancer no longer required surgery, blood loss, or hospital stays? In this episode, we sit down with Dr. Arun Menawat, CEO of Profound Medical, who is leading a bold transformation in prostate cancer care. With Tulsa Pro—an AI-powered, MRI-guided, incision-free therapy—his team is challenging the surgical status quo head-on. Arun shares how his journey through imaging innovation shaped this breakthrough, and why he believes the future of interventional medicine will be bloodless, precise, and radically patient-centric. This one's not just disruptive—it's redefining what cancer treatment can be.